Featured Research

from universities, journals, and other organizations

Radiation Therapy Technique Reduces Length Of Prostate Cancer Treatment

Date:
September 24, 2007
Source:
UT Southwestern Medical Center
Summary:
Breihan Bridgewater suffers from emphysema. He sleeps on his side because when he lays flat on his back it feels like there's a boulder resting on his chest. When the 74-year-old semi-retired electronic technician was diagnosed with prostate cancer, the thought of undergoing surgery or having to lie on his back and undergo more than 40 radiation treatments left him with an uneasy feeling -- and a decision to make.

Dr. Robert Timmerman and radiation therapist, Sheree Kincaid, get patient Breihan Bridgewater ready for treatment.
Credit: Image courtesy of UT Southwestern Medical Center

Breihan Bridgewater suffers from emphysema. He sleeps on his side because when he lays flat on his back it feels like there's a boulder resting on his chest.

When the 74-year-old semi-retired electronic technician was diagnosed with prostate cancer, the thought of undergoing surgery or having to lie on his back and undergo more than 40 radiation treatments left him with an uneasy feeling -- and a decision to make.

The Lewisville resident decided he would not seek treatment for his early-stage prostate cancer.

After Mr. Bridgewater told his UT Southwestern Medical Center doctors that the decision was determined because he didn't believe he could withstand the standard treatment for prostate cancer, they referred him to Dr. Robert Timmerman, vice chairman of radiation oncology.

Dr. Timmerman is leading a national clinical trial testing the effectiveness of stereotactic body radiation therapy (SBRT) to treat prostate cancer in five, 30-minute sessions.

The SBRT technique is a relatively new procedure used for treating localized tumors by delivering very high doses of focused radiation. Dr. Timmerman has successfully used the technique to treat patients with lung and liver cancers.

"There are a number of good treatments for prostate cancer, but they all have some drawbacks -- they're inconvenient; they're invasive; or they cause impotence, rectal injury or urinary incontinence," said Dr. Timmerman.

The three standard treatment options for early stage prostate cancer are:

  1. Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;
  2. Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin. Once implanted, the seeds release their radioactivity directly into the prostate gland; and
  3. External beam radiation, which involves 42 to 45 treatments administered over two or more months, five days a week.

"This new treatment mimics the dose deposition of brachytherapy, but it is done noninvasively, in an outpatient setting, without making any incisions, needle punctures or anesthesia," Dr. Timmerman said. "The beauty of it is that the patient only has to come in for five outpatient treatments and is finished in a week and a half."

Dr. Timmerman has treated 11 patients at UT Southwestern using this new method with only minor side effects. As part of the study, he is trying to establish the treatment's proper dose protocol. He also is establishing study sites at the University of Minnesota, University of Colorado and at a rural practice in South Dakota.

Health-care experts predict that about 218,000 new cases of prostate cancer will be diagnosed in the U.S. this year, and more than 27,000 men will die from the disease.

Dr. Timmerman said the SBRT treatment might be ideal for people who live far away from an academic medical center or who can't stay away from their jobs for extended periods of time to receive treatment or recover.

"We're targeting this population because they clearly need a better treatment," Dr. Timmerman said. "If the treatment ends up being favorable in its toxicity and side effects, then even 'city slickers' might want to have it too."

For Mr. Bridgewater, "the treatment was a breeze. I didn't have to do anything except breathe."

And his prognosis is excellent. Tests show that the level of prostate-specific antigen (PSA) in Mr. Bridgewater's blood, which is elevated in men who have prostate cancer, was nearly nonexistent.

"Actually, we are seeing that the PSA levels in patients undergoing this new therapy are declining more rapidly than one would expect with conventional treatment," Dr. Timmerman said. "It's still early in the study process, but it looks promising."

Participants are still being recruited for the study. To qualify, patients must have early stage prostate cancer and a Gleason score of 7 or below. For more information contact Alida Perkins at 214-645-7633.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Radiation Therapy Technique Reduces Length Of Prostate Cancer Treatment." ScienceDaily. ScienceDaily, 24 September 2007. <www.sciencedaily.com/releases/2007/09/070920091217.htm>.
UT Southwestern Medical Center. (2007, September 24). Radiation Therapy Technique Reduces Length Of Prostate Cancer Treatment. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2007/09/070920091217.htm
UT Southwestern Medical Center. "Radiation Therapy Technique Reduces Length Of Prostate Cancer Treatment." ScienceDaily. www.sciencedaily.com/releases/2007/09/070920091217.htm (accessed April 23, 2014).

Share This



More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com
How to Master Motherhood With the Best Work/Life Balance

How to Master Motherhood With the Best Work/Life Balance

TheStreet (Apr. 22, 2014) In the U.S., there are more than 11 million couples trying to conceive at any given time. From helping celebrity moms like Bethanny Frankel to ordinary soon-to-be-moms, TV personality and parenting expert, Rosie Pope, gives you the inside scoop on mastering motherhood. London-born entrepreneur Pope is the creative force behind Rosie Pope Maternity and MomPrep. She explains why being an entrepreneur offers the best life balance for her and tips for all types of moms. Video provided by TheStreet
Powered by NewsLook.com
Catching More Than Fish: Ugandan Town Crippled by AIDS

Catching More Than Fish: Ugandan Town Crippled by AIDS

AFP (Apr. 22, 2014) The village of Kasensero on the shores of Lake Victoria was where HIV-AIDS was first discovered in Uganda. Its transient population of fishermen and sex workers means the nationwide programme to combat the virus has had little impact. Duration: 02:30 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins